USA - NYSE:DOCS - US26622P1075 - Common Stock
The current stock price of DOCS is 66.84 USD. In the past month the price decreased by -10.16%. In the past year, price increased by 62.04%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.33 | 48.03B | ||
| WAY | WAYSTAR HOLDING CORP | 35.11 | 7.44B | ||
| HTFL | HEARTFLOW INC | N/A | 3.16B | ||
| CERT | CERTARA INC | 25.84 | 2.03B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.67B | ||
| SDGR | SCHRODINGER INC | N/A | 1.66B | ||
| PHR | PHREESIA INC | N/A | 1.41B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 11.29 | 1.37B | ||
| CTEV | CLARITEV CORP | N/A | 1.15B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 917.75M | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 909.88M |
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 830 full-time employees. The company went IPO on 2021-06-24. The company offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
DOXIMITY INC-CLASS A
500 Third Street, Suite 510
San Francisco CALIFORNIA US
CEO: Jeffrey Tangney
Employees: 830
Phone: 16505494330
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 830 full-time employees. The company went IPO on 2021-06-24. The company offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
The current stock price of DOCS is 66.84 USD. The price increased by 0.89% in the last trading session.
DOCS does not pay a dividend.
DOCS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
DOCS stock is listed on the New York Stock Exchange, Inc. exchange.
The PE ratio for DOXIMITY INC-CLASS A (DOCS) is 44.86. This is based on the reported non-GAAP earnings per share of 1.49 and the current share price of 66.84 USD.
You can find the ownership structure of DOXIMITY INC-CLASS A (DOCS) on the Ownership tab.
ChartMill assigns a technical rating of 7 / 10 to DOCS. When comparing the yearly performance of all stocks, DOCS is one of the better performing stocks in the market, outperforming 88.59% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to DOCS. DOCS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months DOCS reported a non-GAAP Earnings per Share(EPS) of 1.49. The EPS increased by 43.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 39.88% | ||
| ROA | 19.52% | ||
| ROE | 22.93% | ||
| Debt/Equity | 0 |
26 analysts have analysed DOCS and the average price target is 70.95 USD. This implies a price increase of 6.14% is expected in the next year compared to the current price of 66.84.
For the next year, analysts expect an EPS growth of 9.67% and a revenue growth 11.96% for DOCS